Literature DB >> 25070780

MicroRNAs as cancer biomarkers.

Nazila Nouraee, George A Calin1.   

Abstract

MicroRNAs (miRNAs) are attractive, short, non-coding RNAs widely studied for their fundamental roles in tissue homeostasis, cell proliferation, and dysregulation in cancer. A vast majority of investigations and technical improvements have focused on miRNAs' tumor-specific expression patterns, which provide novel molecular biomarkers for cancer detection and targeted therapies. In this review, we focus on recent achievements in biomarker validation and potential for cancer treatment, with special trend in non-invasive strategies to evaluate miRNAs, especially for diagnostic and prognostic applications. We further include a large compilation of PubMed data regarding microRNAs reported as diagnostic or prognostic cancer biomarkers in at least three studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 25070780     DOI: 10.2174/22115366113029990015

Source DB:  PubMed          Journal:  Microrna


  7 in total

Review 1.  MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets.

Authors:  Glen Reid
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

2.  A novel signaling role for miR-451 in esophageal tumor microenvironment and its contribution to tumor progression.

Authors:  S Khazaei; N Nouraee; A Moradi; S J Mowla
Journal:  Clin Transl Oncol       Date:  2016-11-28       Impact factor: 3.405

3.  Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis.

Authors:  Maria Vincenza Chiantore; Giorgio Mangino; Marco Iuliano; Maria Simona Zangrillo; Ilaria De Lillis; Gabriele Vaccari; Rosita Accardi; Massimo Tommasino; Sandra Columba Cabezas; Maurizio Federico; Gianna Fiorucci; Giovanna Romeo
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-14       Impact factor: 4.553

Review 4.  microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance.

Authors:  Wen Cai Zhang
Journal:  Int J Mol Sci       Date:  2019-12-03       Impact factor: 5.923

5.  Plasma expression of miRNA-21, - 214, -34a, and -200a in patients with persistent HPV infection and cervical lesions.

Authors:  Hongyun Wang; Dandan Zhang; Qing Chen; Ying Hong
Journal:  BMC Cancer       Date:  2019-10-23       Impact factor: 4.430

Review 6.  The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy.

Authors:  Rui Shi; Xin Zhou; Wen-Jie Ji; Ying-Ying Zhang; Yong-Qiang Ma; Jian-Qi Zhang; Yu-Ming Li
Journal:  Biomed Res Int       Date:  2015-06-28       Impact factor: 3.411

7.  Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.

Authors:  Anja Honegger; Daniela Schilling; Sandra Bastian; Jasmin Sponagel; Vladimir Kuryshev; Holger Sültmann; Martin Scheffner; Karin Hoppe-Seyler; Felix Hoppe-Seyler
Journal:  PLoS Pathog       Date:  2015-03-11       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.